-
Je něco špatně v tomto záznamu ?
Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer
P. Tesarova, T. Zima, AA. Kubena, M. Kalousova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2017
ProQuest Central
od 2017-01-01 do 2018-06-30
Health & Medicine (ProQuest)
od 2017-01-01 do 2018-06-30
Public Health Database (ProQuest)
od 2017-01-01 do 2018-06-30
ROAD: Directory of Open Access Scholarly Resources
od 1987
PubMed
28695773
DOI
10.1177/1010428317702902
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- jednonukleotidový polymorfismus MeSH
- Kaplanův-Meierův odhad MeSH
- laktoylglutathionlyasa genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory prsu genetika mortalita patologie MeSH
- receptor pro konečné produkty pokročilé glykace genetika MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Receptor for advanced glycation end products and glyoxalase I metabolizing advanced glycation end product precursors may play important role in the pathogenesis and progression of cancer. Potential relation between soluble forms of receptor for advanced glycation end products (sRAGE), receptor for advanced glycation end products, glyoxalase I polymorphisms, and long-term outcome (median follow-up of 10.3 years) was studied in 116 patients with breast cancer. Gly82Ser and 2184 A/G RAGE polymorphisms were related to the mortality due to the breast cancer and -419 A/C glyoxalase I polymorphism was related to the overall mortality of the patients suggesting their role not only in the risk of breast cancer but also in the outcome of patients with breast cancer.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17030695
- 003
- CZ-PrNML
- 005
- 20171103103655.0
- 007
- ta
- 008
- 171025s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/1010428317702902 $2 doi
- 035 __
- $a (PubMed)28695773
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tesarova, Petra $u 1 Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 245 10
- $a Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer / $c P. Tesarova, T. Zima, AA. Kubena, M. Kalousova,
- 520 9_
- $a Receptor for advanced glycation end products and glyoxalase I metabolizing advanced glycation end product precursors may play important role in the pathogenesis and progression of cancer. Potential relation between soluble forms of receptor for advanced glycation end products (sRAGE), receptor for advanced glycation end products, glyoxalase I polymorphisms, and long-term outcome (median follow-up of 10.3 years) was studied in 116 patients with breast cancer. Gly82Ser and 2184 A/G RAGE polymorphisms were related to the mortality due to the breast cancer and -419 A/C glyoxalase I polymorphism was related to the overall mortality of the patients suggesting their role not only in the risk of breast cancer but also in the outcome of patients with breast cancer.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a receptor pro konečné produkty pokročilé glykace $x genetika $7 D000067759
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a nádory prsu $x genetika $x mortalita $x patologie $7 D001943
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a laktoylglutathionlyasa $x genetika $7 D007791
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zima, Tomas $u 2 Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Kubena, Ales A $u 2 Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Kalousova, Marta $u 2 Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 39, č. 7 (2017), s. 1010428317702902
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28695773 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171103103749 $b ABA008
- 999 __
- $a ok $b bmc $g 1254288 $s 991722
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 39 $c 7 $d 1010428317702902 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757
- LZP __
- $a Pubmed-20171025
